← Back to Search

NMDA Receptor Antagonist

Ketamine and Epigenetic Aging

Phase 2
Waitlist Available
Research Sponsored by TruDiagnostic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessment will evaluate the correlation of data collected at baseline with data from after treatment is completed, on average five weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing ketamine infusions to help people with depression or PTSD. The treatment involves multiple sessions over a short period. Ketamine may improve mood by changing how brain cells communicate. Ketamine has been shown to have rapid and robust effects on depression, with improvements often seen immediately after administration and lasting for a significant duration.

Eligible Conditions
  • Depression
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~biological age will be compared from baseline to study completion, an average of five weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and biological age will be compared from baseline to study completion, an average of five weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Epigenetic Age
Secondary study objectives
Degree of Treatment Response
Severity of Illness and baseline epigenetic age
Severity of Illness and post-treatment epigenetic age

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ketamine InfusionExperimental Treatment1 Intervention
subanesthetic ketamine infusion (0.5mg/kg) over 2-3 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ketamine
2011
Completed Phase 4
~1120

Find a Location

Who is running the clinical trial?

TruDiagnosticLead Sponsor
11 Previous Clinical Trials
466 Total Patients Enrolled
Wild HealthUNKNOWN
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top